Effect
GH / IGF-1
Raising the body's own growth hormone, and with it IGF-1, through the GHRH or ghrelin receptor in the pituitary gland.
4 compounds in the guide
Educational only. A summary of published research, not medical advice or a recommendation. No doses are listed. Compounds are listed from the strongest evidence to the weakest. Being listed isn't a recommendation.
Related pathways
The receptors and pathways behind this effect.
Compounds
-
Tesamorelin
FDA-approvedA synthetic analogue of growth hormone–releasing hormone (GHRH) that prompts the pituitary to release growth hormone.
-
Sermorelin
Previously approvedA shortened form of growth hormone–releasing hormone made of its first 29 amino acids.
-
CJC-1295
Not approvedA synthetic GHRH analogue designed to last much longer than the body's own GHRH.
-
Ipamorelin
Not approvedA synthetic five-amino-acid growth hormone secretagogue.